...
首页> 外文期刊>Planta medica: Natural products and medicinal plant research >Inhibition of TNF-alpha-Induced Inflammation by Sesquiterpene Lactones from Saussurea lappa and Semi-Synthetic Analogues
【24h】

Inhibition of TNF-alpha-Induced Inflammation by Sesquiterpene Lactones from Saussurea lappa and Semi-Synthetic Analogues

机译:来自Saussurea Lappa和半合成类似物的SesquiterPene内酯的TNF-α诱导的TNF-α诱导的炎症

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated the tumor necrosis factor-alpha (TNF-alpha) inhibitory activity of sesquiterpenes from Saussurea lappa root extracts. According to the hexane and EtOAc extracts showing significant activity with IC50 values of 0.5 and 1.0 mu g/mL, respectively, chromatographic fractionation of the extracts was performed and led to the isolation of 10 sesquiterpenes (110). Costunolide (1), a major compound, and dehydrocostus lactone (4) exhibited high efficiency in decreasing TNF-alpha levels, with IC50 values of 2.05 and 2.06 mu M, respectively. In addition, sesquiterpene analogues were synthesized to establish their structure-activity relationship (SAR) profile. Among the semi-synthetic analogues, compounds 6a and 16 showed the most potent activity with IC50 values of 1.84 and 1.97 mu M, respectively. More importantly, compound 6a showed less toxicity than costunolide and 16. These results provided the first SAR profile of sesquiterpene lactones and indicated that the alpha-methylene-gamma-lactone moiety plays a crucial role in TNF-alpha inhibition. Additionally, the epoxide derivative 6a might represent a lead compound for further anti-TNF-alpha therapies, owing to its potent activity and reduced toxicity.
机译:我们研究了来自Saussurea Lappa根提取物的肿瘤坏死因子-α(TNF-α)癫痫患者的抑制活性。根据己烷和EtOAc提取物,分别显示出具有0.5和1.0μmg/ ml的IC 50值的显着活性,进行萃取物的色谱分级并导致分离10sesquiterpenes(110)。 CostnoLide(1),主要化合物和脱氢蹄甾菌(4)在降低TNF-α水平方面表现出高效率,分别具有2.05和2.06μm的IC 50值。此外,合成了SesquiterPene类似物以建立其结构 - 活性关系(SAR)轮廓。在半合成类似物中,化合物6a和16分别显示出最有效的活性,分别具有1.84和1.97μm的IC 50值。更重要的是,化合物6a显示出比昆粒烯化剂的毒性较小。这些结果提供了倍二萜内酯的第一个SAR曲线,并表明α-亚甲基-γ-内酯部分在TNF-α抑制中起着至关重要的作用。另外,由于其有效的活性和毒性降低,环氧化物衍生物6a可以代表进一步抗TNF-α疗法的铅化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号